Improving Quality of Life
through Transcatheter Cardiac Repair (TCR)
Micro Interventional Devices (MID) is a privately held medical device company that designs, manufactures and commercializes disruptive catheter-based technologies for the treatment of structural heart disease.
The MIA-T Percutaneous Tricuspid Annuloplasty System for the treatment of Tricuspid Regurgitation
MID develops Transcatheter Cardiac Repair (TCR) technologies that eliminate the need for cardiopulmonary bypass.
The Company strives to improve structural heart disease outcomes for the:
Patient: Through less invasive and less morbid procedures.
Surgeon/Interventionalist: Through technology that improves outcomes, reduces operative time and/or improves ease of use.
Healthcare Network: Through cost effective technologies that reduce operative time while exceeding surgical and/or interventional performance criteria.
MIA-T Is an Investigational Device ONLY